目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS & REGIONS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources of secondary data
2.1.1.2 Key objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
2.1.2.2 Key objectives of primary research
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 MARKET SIZE ESTIMATION, 2024
2.2.1.1 Insights from primary sources
2.2.2 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)
2.3 MARKET GROWTH RATE FORECAST
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY
3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS
3.3 DISRUPTIVE TRENDS

4 PREMIUM INSIGHTS
4.1 TANGENTIAL FLOW FILTRATION MARKET SNAPSHOT
4.2 NORTH AMERICA: TANGENTIAL FLOW FILTRATION MARKET, BY PRODUCT & COUNTRY (2024)
4.3 TANGENTIAL FLOW FILTRATION MARKET, BY APPLICATION (2024)
4.4 TANGENTIAL FLOW FILTRATION MARKET, BY END USER (2024)
4.5 TANGENTIAL FLOW FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising technological advancements in TFF systems
5.2.1.2 Rising R&D spending and growth in pharmaceutical & biotechnology industries
5.2.1.3 Increasing adoption of single-use technologies
5.2.1.4 Stringent regulatory requirements for biopharmaceutical products
5.2.2 RESTRAINTS
5.2.2.1 High capital investments to limit entry of small players
5.2.2.2 Issues associated with membrane fouling
5.2.2.3 Competition from alternative technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.3.2 Expansion of biologics & biosimilars pipelines
5.2.3.3 Integration of TFF in continuous bioprocessing workflows
5.2.4 CHALLENGES
5.2.4.1 Impact of PFAS restrictions
5.2.4.2 Complexities introduced by excipient-protein interaction
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022-2024
5.4.2 AVERAGE SELLING PRICE TREND OF TFF PRODUCTS, 2022-2024
5.4.3 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022-2024
5.5 PORTER'S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 BARGAINING POWER OF SUPPLIERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Ultrafiltration
5.6.1.2 Microfiltration
5.6.1.3 Nanofiltration
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 Single-use technology
5.6.2.2 Automation & control software
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Chromatography
5.6.3.2 Centrifugation
5.6.3.3 Microfluidics
5.7 VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
5.8.1 ROLE IN ECOSYSTEM
5.8.2 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
5.9 PATENT ANALYSIS
5.9.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR TANGENTIAL FLOW FILTRATION PATENTS, 2014-2024
5.10 KEY CONFERENCES & EVENTS, 2025-2026
5.11 REGULATORY LANDSCAPE
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2 REGULATORY FRAMEWORK
5.11.2.1 North America
5.11.2.2 Europe
5.11.2.3 Asia Pacific
5.11.2.4 Latin America
5.11.2.5 Middle East & Africa
5.11.3 REGULATORY CHALLENGES IN TANGENTIAL FLOW FILTRATION MARKET
5.11.4 SUSTAINABILITY IMPACT ON TANGENTIAL FLOW FILTRATION MARKET
5.12 TRADE DATA
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA FOR END USERS
5.13.3 UNMET NEEDS OF END USERS
5.14 INVESTMENT & FUNDING SCENARIO
5.14.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE, 2024
5.15 IMPACT OF AI/GENERATIVE AI ON TANGENTIAL FLOW FILTRATION PRODUCTS MARKET
5.15.1 INTRODUCTION
5.15.2 MARKET POTENTIAL OF AI IN TANGENTIAL FLOW FILTRATION APPLICATIONS
5.15.3 AI-USE CASES
5.15.4 KEY COMPANIES IMPLEMENTING AI
5.15.5 FUTURE OF GENERATIVE AI IN TANGENTIAL FLOW FILTRATION ECOSYSTEM
5.16 TRUMP TARIFF IMPACT ON TANGENTIAL FLOW FILTRATION MARKET
5.16.1 INTRODUCTION
5.16.2 KEY TARIFF RATES
5.16.3 PRICE IMPACT ANALYSIS
5.16.4 IMPACT ON COUNTRY/REGION
5.16.4.1 US
5.16.4.2 Europe
5.16.4.3 Asia Pacific
5.16.5 IMPACT ON END-USE INDUSTRIES
5.16.5.1 Pharmaceutical & biotech companies
5.16.5.2 Academic & research institutes
5.16.5.3 Contract research organizations

6 TANGENTIAL FLOW FILTRATION MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 MEMBRANE FILTER DEVICES
6.2.1 CASSETTES
6.2.1.1 Reduction of downtime and elimination of cleaning validation to fuel uptake
6.2.2 CAPSULES & CARTRIDGES
6.2.2.1 Increased flow path and higher efficiency of hollow-fiber filters to boost demand
6.3 SYSTEMS
6.3.1 SINGLE-USE SYSTEMS
6.3.1.1 Reduced need for product validation and minimized cross-contamination risks to boost usage
6.3.2 REUSABLE SYSTEMS
6.3.2.1 Availability of automated & semi-automated varieties to fuel uptake
6.4 OTHER PRODUCTS

7 TANGENTIAL FLOW FILTRATION MARKET, BY MEMBRANE MATERIAL
7.1 INTRODUCTION
7.2 PES
7.2.1 HIGH RELIABILITY AND BROAD APPLICATIONS TO DRIVE MARKET
7.3 REGENERATED CELLULOSE
7.3.1 LOW PROTEIN BINDING & BIOCOMPATIBILITY FEATURES TO FUEL UPTAKE
7.4 PVDF
7.4.1 HIGH DURABILITY AND ENHANCED PERFORMANCE IN INTENSIVE PROCESSES T0 BOOST DEMAND
7.5 PTFE
7.5.1 HIGH CHEMICAL RESISTANCE IN HARSH FILTRATION ENVIRONMENTS TO FUEL UPTAKE
7.6 MCE & CA
7.6.1 COST-EFFECTIVENESS AND FAST FLOW FOR BASIC FILTRATION REQUIREMENTS TO SUPPORT MARKET GROWTH
7.7 PCTE
7.7.1 USAGE IN CELL BIOLOGY & ANALYTICAL TESTING APPLICATIONS TO AID ADOPTION
7.8 NYLON
7.8.1 INCREASED ENDOTOXIN ADSORPTION CAPACITY OF NYLON FILTERS TO DRIVE DEMAND
7.9 OTHER MEMBRANE MATERIALS

8 TANGENTIAL FLOW FILTRATION MARKET, TECHNIQUE
8.1 INTRODUCTION
8.2 ULTRAFILTRATION
8.2.1 EXPANDING APPLICATIONS IN BIOPHARMACEUTICAL INDUSTRY FOR POST-FERMENTATION CELL HARVESTING TO DRIVE MARKET
8.3 MICROFILTRATION
8.3.1 ABILITY FOR BIOMASS RECOVERY & PURIFICATION DURING ANTIBIOTIC PRODUCTION TO BOOST DEMAND
8.4 NANOFILTRATION
8.4.1 INCREASING APPLICATIONS IN PHARMA & BIOTECH INDUSTRY TO PROPEL MARKET
8.5 OTHER TECHNIQUES

9 TANGENTIAL FLOW FILTRATION MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 FINAL PRODUCT PROCESSING
9.2.1 API FILTRATION
9.2.1.1 Need for continuous filtration of APIs to drive market
9.2.2 PROTEIN PURIFICATION
9.2.2.1 Recent advancements in protein therapeutic drugs to fuel uptake
9.2.3 VACCINE & ANTIBODY PROCESSING
9.2.3.1 Development of vaccines for viral diseases to boost demand
9.2.4 FORMULATION & FILLING SOLUTIONS
9.2.4.1 Rising need for aseptic filling and bioburden reduction to support market growth
9.2.5 VIRAL CLEARANCE
9.2.5.1 Increasing development of therapeutic monoclonal antibodies to boost usage
9.3 RAW MATERIAL FILTRATION
9.3.1 MEDIA & BUFFER FILTRATION
9.3.1.1 Growth in biopharmaceutical manufacturing to drive market
9.3.2 PREFILTRATION
9.3.2.1 Issues associated with membrane fouling to boost demand
9.3.3 BIOBURDEN TESTING
9.3.3.1 Stringent quality control of biopharmaceuticals to support market growth
9.4 CELL SEPARATION
9.4.1 RISING DEMAND FOR PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
9.5 WATER PURIFICATION
9.5.1 GROWING FOCUS ON PURIFIED WATER FOR BIOPHARMACEUTICAL PROCESSES TO FUEL UPTAKE

10 TANGENTIAL FLOW FILTRATION MARKET, BY SCALE OF OPERATION
10.1 INTRODUCTION
10.2 MANUFACTURING SCALE OPERATIONS
10.2.1 GROWING FOCUS ON LARGE VOLUME BIOPRODUCTION AND HIGH-THROUGHPUT TFF SOLUTIONS TO DRIVE MARKET
10.3 PILOT SCALE OPERATIONS
10.3.1 RISING OUTSOURCING OF SERVICES TO BOOST DEMAND
10.4 R&D SCALE OPERATIONS
10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO SUPPORT MARKET GROWTH

11 TANGENTIAL FLOW FILTRATION MARKET, BY END USER
11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.2.1 DEVELOPMENT & PRODUCTION OF BIOLOGICS, BIOSIMILARS, AND ADVANCED THERAPIES TO PROPEL MARKET
11.3 CONTRACT RESEARCH ORGANIZATIONS
11.3.1 RISING DEMAND FOR OUTSOURCING OF CLINICAL ACTIVITIES TO FUEL MARKET
11.4 ACADEMIC & RESEARCH INSTITUTES
11.4.1 INCREASING PHARMA-ACADEMIA COLLABORATIONS TO SUPPORT MARKET GROWTH

12 TANGENTIAL FLOW FILTRATION MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
12.2.2 US
12.2.2.1 High healthcare expenditure and presence of stringent regulatory guidelines for product approvals to drive market
12.2.3 CANADA
12.2.3.1 Favorable government support for expansion of biologics manufacturing facilities to fuel market
12.3 EUROPE
12.3.1 EUROPE: MACROECONOMIC OUTLOOK
12.3.2 GERMANY
12.3.2.1 Expansion in biologics & biosimilar production to fuel market
12.3.3 UK
12.3.3.1 Rising demand for high-quality drugs and increasing uptake of filtration processes to boost market
12.3.4 FRANCE
12.3.4.1 Government investments in pharmaceutical industry to drive market
12.3.5 ITALY
12.3.5.1 Availability of funding for NME development to support market growth
12.3.6 SPAIN
12.3.6.1 Rising focus on development of targeted therapeutics to drive market
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
12.4.2 CHINA
12.4.2.1 Rising incidence of infectious diseases to propel market
12.4.3 JAPAN
12.4.3.1 Growing focus on pharmaceutical research and potential hub for CRO services to drive market
12.4.4 INDIA
12.4.4.1 Favorable scenario for foreign direct investments to favor market growth
12.4.5 SOUTH KOREA
12.4.5.1 Growth in biotechnology industry to fuel market
12.4.6 AUSTRALIA
12.4.6.1 Rising demand for innovative filtration solutions to support market growth
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
12.5.2 BRAZIL
12.5.2.1 Expansion of clinical research activities to support market growth
12.5.3 MEXICO
12.5.3.1 Increasing demand for chronic disease management treatment to fuel uptake
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
12.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
12.6.2 GCC COUNTRIES
12.6.2.1 Kingdom of Saudi Arabia (KSA)
12.6.2.1.1 Growth in healthcare sector to drive market
12.6.2.2 United Arab Emirates (UAE)
12.6.2.2.1 Adoption of efficient & precise filtration processes to drive market
12.6.2.3 Other GCC Countries
12.6.3 REST OF MIDDLE EAST
12.7 AFRICA
12.7.1 INCREASING FOCUS ON PHARMACEUTICAL R&D TO SUPPORT MARKET GROWTH
12.7.2 AFRICA: MACROECONOMIC OUTLOOK

13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TANGENTIAL FLOW FILTRATION MARKET
13.3 REVENUE ANALYSIS, 2020-2024
13.4 MARKET SHARE ANALYSIS, 2024
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Product footprint
13.5.5.4 Application footprint
13.5.5.5 Scale of operation footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS

14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 DANAHER CORPORATION
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches
14.1.1.3.2 Deals
14.1.1.3.3 Expansions
14.1.1.3.4 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices made
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 MERCK KGAA
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Deals
14.1.2.3.2 Expansions
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 SARTORIUS AG
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 REPLIGEN CORPORATION
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches
14.1.4.3.2 Deals
14.1.4.3.3 Expansions
14.1.4.3.4 Other developments
14.1.4.4 MnM view
14.1.4.4.1 Key strengths
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 PARKER-HANNIFIN CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Expansions
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 ALFA LAVAL CORPORATE AB
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.7 ANDRITZ
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.8 DONALDSON COMPANY
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.9 MEISSNER FILTRATION PRODUCTS, INC.
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 ANTYLIA SCIENTIFIC
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Other developments
14.1.11 KOVALUS SEPARATION SOLUTIONS
14.1.11.1 Products offered
14.1.11.2 Recent developments
14.1.11.2.1 Deals
14.1.12 SYNDER FILTRATION, INC.
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 ABEC, INC.
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 FORMULATRIX, INC.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 VERDOT
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 STERLITECH CORPORATION
14.2.2 APPLEXION
14.2.3 PENDOTECH
14.2.4 MICROFILT INDIA PVT. LTD.
14.2.5 BIONET
14.2.6 HANGZHOU COBETTER FILTRATION EQUIPMENT CO., LTD.
14.2.7 SMARTFLOW TECHNOLOGIES, INC.
14.2.8 TAMI INDUSTRIES
14.2.9 ZETA BIOSYSTEM
14.2.10 JIANGSU HANBON SCIENCE & TECHNOLOGY CO., LTD.
14.2.11 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING

15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS